Name | Cyclopropanecarboxamide, 1-(1,3-benzodioxol-5-yl)-N-[5-[(S)-(2-chlorophenyl)[(3R)-3-hydroxy-1-pyrrolidinyl]methyl]-2-thiazolyl] |
---|
Description | VRT-534 targets connexin 26 (Cx26). Vrt-534 exhibits dose-responsive binding to recombinant WT Cx26 and mutant Cx26 K188N with EC50 value of 19 μM and 5 μM, respectively. Vrt-534 can be used in research related to hearing impairment[1]. |
---|---|
Related Catalog | |
Target |
Cx26:19 μM (EC50) |
References |
Density | 1.510±0.06 g/cm3 (20 °C, 760 mmHg) |
---|---|
Molecular Formula | C25H24ClN3O4S |
Molecular Weight | 497.99 |
Exact Mass | 497.11800 |
PSA | 112.16000 |
LogP | 4.36240 |